NCT06590038

Brief Summary

The goal of this clinical trial is to learn whether an single session intervention can reduce psychological impairment in adult individuals with moderate depression. The main questions it aims to answer are: Is this evidence-based intervention acceptable to study participants? Is this evidence-based intervention feasible to implement in a single session? Is there evidence that the evidence-based intervention reduces psychological impairment in adults with moderate to severe depression? Participants will complete:

  • an in-depth diagnostic screening interview prior to enrollment
  • a set of mental health questionnaires at baseline and two weeks post-intervention
  • a 3-hour, evidence-based, single session psychotherapeutic intervention with a trained clinician

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 5, 2024

Completed
14 days until next milestone

First Posted

Study publicly available on registry

September 19, 2024

Completed
6 months until next milestone

Study Start

First participant enrolled

March 3, 2025

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 24, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 24, 2025

Completed
Last Updated

June 4, 2025

Status Verified

May 1, 2025

Enrollment Period

2 months

First QC Date

September 5, 2024

Last Update Submit

June 3, 2025

Conditions

Keywords

DepressionMajor Depressive DisorderPsychotherapySingle Session Intervention

Outcome Measures

Primary Outcomes (1)

  • CARED Treatment Experience Survey

    A brief survey which probes the qualitative experience of participants during the intervention (i.e., tolerability, their level of engagement, satisfaction with treatment). Participants respond to eight items, rated on a 4-point Likert scale (1 - Not at all to 4 - Completely) to indicate their level of agreement with each item. Higher scores on the measure indicate greater tolerability, satisfaction, and endorsement of treatment. Total possible scores range from 8 to 32.

    Immediately post-intervention (same day)

Secondary Outcomes (14)

  • Change from baseline on Behavioral Activation Scale at two weeks post-intervention

    Baseline and Two Weeks post-intervention

  • Change in baseline Repetitive Thinking Questionnaire - 10 item form to two weeks post-intervention

    Baseline and Two weeks post-intervention

  • Change from baseline on Snaith-Hamilton Pleasure Scale at two weeks post-intervention

    Baseline and Two weeks post-intervention

  • Change from baseline on Behavioral Inhibition and Behavioral Activation Scale - Inhibition Subscale at two weeks post-intervention

    Baseline and Two weeks post-intervention

  • Change from baseline on Behavioral Inhibition and Behavioral Activation Scale - Activation Drive Subscale at two weeks post-intervention

    Baseline and Two weeks post-intervention

  • +9 more secondary outcomes

Study Arms (1)

Psychotherapy Arm

EXPERIMENTAL
Behavioral: Single Session Psychotherapy Intervention

Interventions

This is a single session intervention which incorporates elements from second- and third wave psychotherapies (Acceptance and Commitment Therapy and Behavioral Activation), as well as basic psychoeducation. Session will take approximately three hours in total, with the option for breaks between blocks of session.

Psychotherapy Arm

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age of 18 years or older
  • Able to provide informed consent
  • Willing to comply with all study procedures and be available for the duration of the study
  • Speak and understand English
  • Diagnostic and Statistical Manual (DSM)-5 diagnosis of major depressive disorder (MDD) as confirmed by semi-structured clinical assessment
  • Meet a cutoff of at least a moderate depression score on the Beck Depression Inventory (BDI-II) (≥ 20)

You may not qualify if:

  • Participants must not have current active suicide intent as determined by the Columbia Suicide Severity Rating Scale (C-SSRS)
  • Participants must not meet criteria for current severe substance use disorder, anorexia nervosa, or active psychosis as assessed by psychodiagnostic assessment
  • Any participants taking psychotropic medication must be on a stable dose for at least 4 weeks with no planned dose changes within the next 4 weeks.
  • Participants able to birth must not be pregnant or breastfeeding.
  • Participants may not have any medical or neurological illness for which symptom presentation or treatment could interfere with study participation
  • Participants may not have undergone prior brain surgery
  • Participants may not have any brain devices/implants, including cochlear implants and aneurysm clips
  • Participants may not have had brain injury or concussion within the last three months
  • Participants may not have a history of brain injury requiring current treatment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Carolina Center for Neurostimulation

Chapel Hill, North Carolina, 27516, United States

Location

MeSH Terms

Conditions

Depressive DisorderDepressionDepressive Disorder, Major

Condition Hierarchy (Ancestors)

Mood DisordersMental DisordersBehavioral SymptomsBehavior

Study Officials

  • Flavio Frohlich, Ph.D.

    Univeristy of North Carolina Chapel Hill

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 5, 2024

First Posted

September 19, 2024

Study Start

March 3, 2025

Primary Completion

April 24, 2025

Study Completion

April 24, 2025

Last Updated

June 4, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will share

Deidentified individual data that supports the results will be shared beginning 9 to 36 months following publication provided the investigator who proposes to use the data has approval from an Institutional Review Board (IRB), Independent Ethics Committee (IEC), or Research Ethics Board (REB), as applicable, and executes a data use/sharing agreement with UNC.

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
Time Frame
Individual participant data (IPD) and supporting information will be available nine to thirty-six months following publication.
Access Criteria
Individual researchers and research groups will be able to request access to deidentified IPD and supporting information with approved IRB, IEC, or REB and an executed Data Use Agreement (DUA) with University of North Carolina (UNC) Chapel Hill.
More information

Locations